Your browser doesn't support javascript.
loading
Optimization of 8-oxoadenines with toll-like-receptor 7 and 8 activity.
Bazin, Hélène G; Bess, Laura S; Livesay, Mark T; Li, Yufeng; Cybulski, Van; Miller, Shannon M; Johnson, David A; Evans, Jay T.
Afiliação
  • Bazin HG; Center for Translational Medicine, University of Montana, Missoula, MT 59812, United States; Department of Biomedical and Pharmaceutical Sciences, University of Montana, Missoula, MT 59812, United States; GSK Vaccines, 553 Old Corvallis Road, Hamilton, MT 59840, United States. Electronic address: he
  • Bess LS; Center for Translational Medicine, University of Montana, Missoula, MT 59812, United States; Department of Biomedical and Pharmaceutical Sciences, University of Montana, Missoula, MT 59812, United States; GSK Vaccines, 553 Old Corvallis Road, Hamilton, MT 59840, United States.
  • Livesay MT; Center for Translational Medicine, University of Montana, Missoula, MT 59812, United States; Department of Biomedical and Pharmaceutical Sciences, University of Montana, Missoula, MT 59812, United States; GSK Vaccines, 553 Old Corvallis Road, Hamilton, MT 59840, United States.
  • Li Y; GSK Vaccines, 553 Old Corvallis Road, Hamilton, MT 59840, United States.
  • Cybulski V; Center for Translational Medicine, University of Montana, Missoula, MT 59812, United States; Division of Biological Sciences, University of Montana, Missoula, MT 59812, United States; GSK Vaccines, 553 Old Corvallis Road, Hamilton, MT 59840, United States.
  • Miller SM; Center for Translational Medicine, University of Montana, Missoula, MT 59812, United States; Division of Biological Sciences, University of Montana, Missoula, MT 59812, United States.
  • Johnson DA; GSK Vaccines, 553 Old Corvallis Road, Hamilton, MT 59840, United States.
  • Evans JT; Center for Translational Medicine, University of Montana, Missoula, MT 59812, United States; Division of Biological Sciences, University of Montana, Missoula, MT 59812, United States; GSK Vaccines, 553 Old Corvallis Road, Hamilton, MT 59840, United States.
Bioorg Med Chem Lett ; 30(6): 126984, 2020 03 15.
Article em En | MEDLINE | ID: mdl-32001135
ABSTRACT
Toll-like receptors 7 and 8 (TLR7/8) agonists are potent immunostimulants that are attracting considerable interest as vaccine adjuvants. We recently reported the synthesis of a new series of 2-O-butyl-8-oxoadenines substituted at the 9-position with various linkers and N-heterocycles, and showed that TLR7/8 selectivity, potency and cytokine induction could be modulated by varying the alkyl linker length and the N-heterocyclic ring. In the present study, we further optimized the oxoadenine scaffold by investigating the effect of different substituents at the 2-position of the oxoadenine on TLR7/8 potency/selectivity, cytokine induction and DC maturation in human PBMCs. The results show that introducing a 1-(S)-methylbutoxy group at the 2-position of the oxoadenine significantly increased potency for TLR7/8 activity, cytokine induction and DC maturation.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Adenina / Adjuvantes Imunológicos / Receptor 7 Toll-Like / Receptor 8 Toll-Like Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Adenina / Adjuvantes Imunológicos / Receptor 7 Toll-Like / Receptor 8 Toll-Like Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article